Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.
Bansal, Dhruv; Vij, Kiran; Chang, Gue Su; Miller, Christopher A; DiPersio, John F; Vij, Ravi; Heath, Sharon E; Westervelt, Peter; Welch, John S; Fehniger, Todd A.
; 103(6): e270-e273, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29567774
[Neoantigens Are Critical Targets in Naturally and Therapeutically Induced Immune Responses to Cancer].
How One Thing Led to Another.
MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival.
Modulation of Target Antigen Density Improves CAR T-cell Functionality and Persistence.
Intratumoural evolutionary landscape of high-risk prostate cancer: the PROGENY study of genomic and immune parameters.
NLRC3 Restrains Responses to a T.
Chimeric antigen receptor-modified T cells for acute lymphoid leukemia.
Optimized depletion of chimeric antigen receptor T cells in murine xenograft models of human acute myeloid leukemia.
Coronin-1, King of Alloimmunity.